questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Peptide hydrolases
Exopeptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases : Questions médicales fréquentes
Diagnostic
5
Dipeptidyl-Peptidases
Diagnostic
Tripeptidyl-Peptidases
Tests de laboratoire
Symptômes
Dipeptidyl-Peptidases
Anticorps
Dipeptidyl-Peptidases
Historique médical
Diagnostic
Symptômes
5
Symptômes
Dipeptidyl-Peptidases
Tripeptidyl-Peptidases
Troubles digestifs
Maladies auto-immunes
Symptômes
Maladie cœliaque
Symptômes
Prévention
5
Prévention
Dipeptidyl-Peptidases
Examens médicaux
Dipeptidyl-Peptidases
Habitudes alimentaires
Prévention
Stress
Dipeptidyl-Peptidases
Traitements
5
Traitement
Dipeptidyl-Peptidases
Alimentation
Dipeptidyl-Peptidases
Médicaments
Dipeptidyl-Peptidases
Thérapie génique
Dipeptidyl-Peptidases
Probiotiques
Dipeptidyl-Peptidases
Complications
5
Complications
Dipeptidyl-Peptidases
Réversibilité
Dipeptidyl-Peptidases
Maladies chroniques
Dipeptidyl-Peptidases
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Dipeptidyl-Peptidases
Maladies gastro-intestinales
Facteurs de risque
Mode de vie
Facteurs de risque
Génétique
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases : Questions médicales les plus fréquentes",
"headline": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dipeptidyl-Peptidases and Tripeptidyl-Peptidases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-08",
"dateModified": "2026-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Exopeptidases",
"url": "https://questionsmedicales.fr/mesh/D020689",
"about": {
"@type": "MedicalCondition",
"name": "Exopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D020689",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.350"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cathepsine C",
"alternateName": "Cathepsin C",
"url": "https://questionsmedicales.fr/mesh/D020789",
"about": {
"@type": "MedicalCondition",
"name": "Cathepsine C",
"code": {
"@type": "MedicalCode",
"code": "D020789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.350.350.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Peptidyl-Dipeptidase A",
"alternateName": "Peptidyl-Dipeptidase A",
"url": "https://questionsmedicales.fr/mesh/D007703",
"about": {
"@type": "MedicalCondition",
"name": "Peptidyl-Dipeptidase A",
"code": {
"@type": "MedicalCode",
"code": "D007703",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.350.350.687"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"alternateName": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"code": {
"@type": "MedicalCode",
"code": "D004152",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Karine Santos",
"url": "https://questionsmedicales.fr/author/Karine%20Santos",
"affiliation": {
"@type": "Organization",
"name": "4TEEN4 Pharmaceuticals GmbH, Hennigsdorf, Germany."
}
},
{
"@type": "Person",
"name": "Grazia Malovan",
"url": "https://questionsmedicales.fr/author/Grazia%20Malovan",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry, Graz University of Technology, Austria."
}
},
{
"@type": "Person",
"name": "Shalinee Jha",
"url": "https://questionsmedicales.fr/author/Shalinee%20Jha",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry, Graz University of Technology, Austria."
}
},
{
"@type": "Person",
"name": "Peter Macheroux",
"url": "https://questionsmedicales.fr/author/Peter%20Macheroux",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry, Graz University of Technology, Austria."
}
},
{
"@type": "Person",
"name": "Dong Zhao",
"url": "https://questionsmedicales.fr/author/Dong%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Beijing Key Laboratory of Diabetes Prevention and Research, Center for Endocrine Metabolic and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Dipeptidyl peptidase-4 inhibitor-related renal disease.",
"datePublished": "2023-09-01",
"url": "https://questionsmedicales.fr/article/37678056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jdiacomp.2023.108590"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of an Additional Metal-Binding Site in Human Dipeptidyl Peptidase III.",
"datePublished": "2023-08-13",
"url": "https://questionsmedicales.fr/article/37628928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241612747"
}
},
{
"@type": "ScholarlyArticle",
"name": "Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus.",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37356725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.diabres.2023.110798"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohort.",
"datePublished": "2023-07-21",
"url": "https://questionsmedicales.fr/article/37482013",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcrc.2023.154383"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dipeptidyl peptidases and E3 ligases of N-degron pathways cooperate to regulate protein stability.",
"datePublished": "2024-06-14",
"url": "https://questionsmedicales.fr/article/38874443",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1083/jcb.202311035"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Peptide hydrolases",
"item": "https://questionsmedicales.fr/mesh/D010447"
},
{
"@type": "ListItem",
"position": 6,
"name": "Exopeptidases",
"item": "https://questionsmedicales.fr/mesh/D020689"
},
{
"@type": "ListItem",
"position": 7,
"name": "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"item": "https://questionsmedicales.fr/mesh/D004152"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Comment diagnostiquer une déficience en dipeptidyl-peptidases ?\nQuels tests sont utilisés pour évaluer les tripeptidyl-peptidases ?\nQuels symptômes indiquent un problème enzymatique ?\nPeut-on détecter des anticorps contre ces enzymes ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004152#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Quels sont les symptômes d'une déficience en dipeptidyl-peptidases ?\nComment se manifestent les troubles liés aux tripeptidyl-peptidases ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes associés à des maladies auto-immunes ?\nLes symptômes sont-ils similaires à ceux d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D004152#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Comment prévenir les déficiences enzymatiques ?\nLes examens réguliers sont-ils nécessaires ?\nY a-t-il des vaccins pour prévenir ces troubles ?\nLes habitudes alimentaires influencent-elles la prévention ?\nLe stress a-t-il un impact sur ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D004152#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Quels traitements existent pour les déficiences enzymatiques ?\nLes modifications alimentaires sont-elles recommandées ?\nY a-t-il des médicaments spécifiques pour ces enzymes ?\nComment la thérapie génique pourrait-elle aider ?\nLes probiotiques peuvent-ils aider dans ces cas ?",
"url": "https://questionsmedicales.fr/mesh/D004152#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Quelles complications peuvent survenir avec une déficience ?\nLes complications sont-elles réversibles ?\nY a-t-il un risque accru de maladies chroniques ?\nLes complications affectent-elles la qualité de vie ?\nComment gérer les complications liées à ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D004152#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dipeptidyl-Peptidases and Tripeptidyl-Peptidases",
"description": "Quels sont les facteurs de risque pour les déficiences enzymatiques ?\nL'âge est-il un facteur de risque ?\nLes maladies gastro-intestinales augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque ?\nY a-t-il des risques liés à la génétique ?",
"url": "https://questionsmedicales.fr/mesh/D004152#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en dipeptidyl-peptidases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant l'activité enzymatique peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les tripeptidyl-peptidases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses biochimiques spécifiques peuvent être réalisées pour évaluer leur activité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème enzymatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles digestifs, des malabsorption ou des déséquilibres hormonaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anticorps contre ces enzymes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests immunologiques peuvent détecter des anticorps spécifiques contre ces enzymes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des maladies sous-jacentes pouvant affecter l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en dipeptidyl-peptidases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des diarrhées."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles liés aux tripeptidyl-peptidases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles digestifs et des déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation enzymatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à des maladies auto-immunes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies auto-immunes peuvent entraîner des symptômes digestifs et hormonaux."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à ceux d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux de la maladie cœliaque ou d'autres troubles digestifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déficiences enzymatiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces déficiences."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies enzymatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de vaccins spécifiques pour prévenir les déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut réduire le risque de déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur ces enzymes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la digestion et la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments enzymatiques peuvent être prescrits pour améliorer la digestion."
}
},
{
"@type": "Question",
"name": "Les modifications alimentaires sont-elles recommandées ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en protéines et faible en sucres raffinés est souvent conseillée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour ces enzymes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques ciblant directement ces enzymes."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique pourrait-elle aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique pourrait potentiellement corriger les déficiences enzymatiques à l'avenir."
}
},
{
"@type": "Question",
"name": "Les probiotiques peuvent-ils aider dans ces cas ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les probiotiques peuvent améliorer la santé intestinale et la digestion."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications digestives, des malnutritions et des déséquilibres hormonaux peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience enzymatique peut augmenter le risque de maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications digestives peuvent significativement affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à ces enzymes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion appropriée inclut un suivi médical régulier et des ajustements alimentaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les déficiences enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les maladies auto-immunes et une alimentation déséquilibrée sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut réduire l'activité enzymatique et augmenter le risque de déficiences."
}
},
{
"@type": "Question",
"name": "Les maladies gastro-intestinales augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie cœliaque peuvent affecter l'activité des enzymes."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de déficiences."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la génétique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques peuvent prédisposer à des déficiences enzymatiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
4TEEN4 Pharmaceuticals GmbH, Hennigsdorf, Germany.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Institute of Biochemistry, Graz University of Technology, Austria.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Institute of Biochemistry, Graz University of Technology, Austria.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Institute of Biochemistry, Graz University of Technology, Austria.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Beijing Key Laboratory of Diabetes Prevention and Research, Center for Endocrine Metabolic and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria 3010, Australia.
Gynaecology Research Centre, Royal Women's Hospital, Parkville, Victoria 3052, Australia.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Medicine and Cell Research, Medical Faculty, University of Freiburg, Freiburg, Germany.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Medicine and Cell Research, Medical Faculty, University of Freiburg, Freiburg, Germany. Electronic address: ruth.geiss-friedlander@mol-med.uni-freiburg.de.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
P.I.I.F. Tazuke-Kofukai Medical Research Institute KITANO HOSPITAL, Osaka, Japan.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
2 publications dans cette catégorie
Affiliations :
b Department of Biophysics and Radiology, Faculty of Medicine , Josip Juraj Strossmayer University of Osijek , Osijek , Croatia.
c Department of Biophysics and Radiology, Faculty of Dental Medicine and Health , Josip Juraj Strossmayer University of Osijek , Osijek , Croatia.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23, Uppsala, Sweden. Electronic address: Birgitta.Tomkinson@imbim.uu.se.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiac and Vascular Surgery, Dokkyo Medical University School of Medicine, Mibu 321-0293, Tochigi, Japan.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
1 publication dans cette catégorie
Affiliations :
Department of Medical KAATSU Training, Dokkyo Medical University School of Medicine, Mibu 321-0293, Tochigi, Japan.
Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Mibu 321-0293, Tochigi, Japan.
Publications dans "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" :
Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used to treat type 2 diabetes (T2D). Lowering blood glucose is expected also to reduce the progression of diabetic nephropathy. We experienced a pa...
Out of 56 patients with biopsy-proven diabetic nephropathy who underwent native kidney biopsy at Toranomon Hospital from January 2018 through December 2022, we selected 22 patients who had been receiv...
Group A had a median (interquartile range [IQR]) eGFR of 18.2 (16.2, 26.2) and a yearly median (IQR) eGFR slope of -11.2 (-17.6, -9.2) mL/min/1.73 m...
DPP-4 inhibitors promote vascular endothelial regeneration, but when this effect occurs in the glomerulus, glomerular endothelial cell proliferation leads to TMA-like lesions, which may cause an incre...
Dipeptidyl peptidase III (DPP III, EC 3.4.14.4) is a monozinc metalloexopeptidase that hydrolyzes dipeptides from the N-terminus of peptides consisting of three or more amino acids. Recently, DPP III ...
The question of whether dipeptidyl peptidase-4 inhibitors (DPP-4i) should be preferred as new glucose-lowering agents in heart failure is controversial. This studyaimed to evaluate the effects of DPP-...
We searched for available studies of DPP-4i therapy in heart failure and performed a pooled analysis. Outcomes included all-cause mortality, cardiovascular death, hospitalization for heart failure, le...
Treatment with DPP-4i did not reduce the risk of all-cause death, cardiovascular death, or hospitalization for heart failure. Subgroup analyses showed that DPP-4i significantly reduced all-cause morta...
DPP-4i may reduce all-cause mortality in heart failure patients in subgroups of women and HFpEF and has a high coronary safety profile....
Biomarkers independently associated with outcome of intensive care unit (ICU) patients can improve risk assessment. The cytosolic protease dipeptidyl-peptidase 3 (DPP3) is released into the circulatio...
Prospective observational study in 650 adult ICU patients. cDPP3 concentrations were measured at ICU admission (day 1), and on days 2 and 3....
cDPP3 concentrations on days 1 and 2, but not on day 3 were associated with 28-day mortality; HR 1.36 (95%CI 1.01-1.83, p = 0.043) and HR 1.49 (95%CI 1.16-1.93, p = 0.002) for days 1 and 2, respective...
In a mixed-ICU cohort, cDPP3 concentrations after start of initial treatment were independently associated with both mortality and development of AKI. Therefore, measurement of cDPP3 can improve risk-...
N-degrons are short sequences located at protein N-terminus that mediate the interaction of E3 ligases (E3s) with substrates to promote their proteolysis. It is well established that N-degrons can be ...
Considerable effort has been made to achieve less frequent dosing in the development of DPP-4 inhibitors. Enthusiasm for long-acting DPP-4 inhibitors is based on the promise that such agents with less...
Systematic low-grade inflammation is considered to be an important factor leading to the development of T2DM and the progression of its complications. Dipeptidyl-peptidase-4 (DPP-4) inhibitors show po...
A comprehensive search was performed in PubMed, Web of Science, Embase, and Cochrane Central Register of Controlled Trials to identify randomized controlled trials that assess the anti-inflammatory ef...
Twenty-two studies with 1595 patients with T2DM were included. Pooled results showed that DPP-4 inhibitor therapy was significantly associated with the reduction of C-reactive protein (CRP) (SMD, - 0....
This meta-analysis demonstrated that DPP-4 inhibitors can significantly attenuate low-grade inflammatory state in patients with T2DM. In addition to improving glycemic control, DDP-4 inhibitors might ...
Sodium load increases endogenous glucagon-like peptide-1 (GLP-1) levels in humans. Therefore, patients with an increased amount of dietary sodium intake are supposed to have higher endogenous GLP-1 le...
Medical records of patients with T2DM prescribed DPP-4i in the last 11 years were investigated. Dietary sodium intake was measured before the DPP-4i prescription with Tanaka's formula using casual spo...
DPP-4i improved HbA1c by -0.41% ± 0.66%. The effect of DPP-4i on glycemic control was significantly negatively correlated with the dietary sodium intake (r = -0.400). Thus, the more dietary sodium int...
Thus, patients can expect better plasma glucose control by DPP-4is if patients are taking increased dietary sodium intake....
Traditional Chinese medicine (TCM) possesses unique advantages in the management of blood glucose and lipids. However, there is still a significant gap in the exploration of its pharmacologically acti...
Adverse drug reactions are one of the contributors to increased hospital admission and length of hospital stay. Among the various antidiabetic agents prescribed, dipeptidyl peptidase-4 (DPP-4) inhibit...
We followed Preferred Reporting Items for Scoping Review (PRISMA-ScR) Guidelines for reporting the findings. Data sources such as PubMed/MEDLINE, Scopus, Embase, and Cochrane were assessed. We include...
Of the 6406 studies retrieved, 11 studies met our inclusion criteria. Of these 11 studies, seven were post-marketing surveillance studies, one nested case-control study, one comparator cohort study, o...
The included studies suggested age >65 years, females, grade 4 and 5 renal impairment, concomitant drugs, disease and drug therapy duration, liver disease, non-smokers, and non-hypertension as risk fa...
CRD42022308764....